What is Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF)?

Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of KBBTF?

The current price of KBBTF is $0.96. Prices are updated in real time on Stocks360.

What is KBBTF's market capitalization?

KBBTF's market capitalization is $24,097,728.00, placing it in the small-cap tier.

Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.96

Market Cap

$24.10M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.18

Day Range

$0.96 – $0.96

52-wk Range

$0.96 – $2.81

Avg Volume

N/A

Volume

905.00

Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) is a publicly traded company in the Healthcare sector. Latest price: $0.96. Market cap $24.10M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Kubota Pharmaceutical Holdings Co., Ltd.

Kubota Pharmaceutical Holdings Co., Ltd. operates globally, concentrating on the development of innovative drugs and medical devices within the ophthalmology sector. A key asset in its product pipeline is emixustat hydrochloride, which is currently undergoing Phase III clinical trials for Stargardt disease and Phase II trials for proliferative diabetic retinopathy. The company is also advancing a remote, patient self-monitoring optical coherence tomography (OCT) device designed for home use, intended to address conditions like wet age-related macular degeneration and diabetic macular edema, which are characterized by retinal swelling and reduced visual acuity. Furthermore, it is developing a wearable device aimed at controlling myopia. This Tokyo, Japan-based company was founded in 2002.